Author:
Le Corroller Anne-Gaëlle,Bonastre Julia
Publisher
Springer Science and Business Media LLC
Subject
Health Policy,Economics, Econometrics and Finance (miscellaneous)
Reference24 articles.
1. Meadows, K.A.: Patient-reported outcome measures: an overview. Br. J. Commun. Nurs. 16(3), 146–151 (2011)
2. DeMuro, C., Clark, M., Doward, L., Evans, E., Mordin, M., Gnanasakthy, A.: Assessment of PRO label claims granted by the FDA as compared to the EMA (2006–2010). Value Health 16(8), 1150–1155 (2013)
3. Gnanasakthy, A., Barrett, A., Evans, E., D’Alessio, D., Romano, C.D.: A review of patient-reported outcomes labeling for oncology drugs approved by the FDA and the EMA (2012–2016). Value Health 22(2), 203–209 (2019)
4. Marquis, P., Caron, M., Emery, M.-P., Scott, J.A., Arnould, B., Acquadro, C.: The role of health-related quality of life data in the drug approval processes in the US and Europe. Pharm. Med. 25, 147–160 (2011)
5. FDA. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims. In: Research CfDEa (ed.) (2019).
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献